Ascom’s 2024 Financial Overview
Ascom recently reported its financial results for 2024, showcasing a mix of challenges and opportunities for growth despite a declining revenue stream. The company's net revenue reached CHF 286.7 million, reflecting a decrease compared to the CHF 297.3 million achieved in 2023. This decline equates to a 1.6% decrease when looking at constant currencies and a 3.6% drop at actual currencies. Navigating through a tough market, Ascom's performance this past year has illustrated both the resilience and the hurdles faced by the organization.
Diving Deeper into Revenue Performance
The decline in revenue was most pronounced in the earlier half of 2024, where figures were reported to be 2.7% lower than the previous year at constant currencies. In contrast, the second half of the year saw stabilization, matching the previous year’s performance. The sector breakdown revealed that the Healthcare market comprises the majority of revenue at 67%, while the Enterprise market remained steady at 28%. Furthermore, the OEM segment witnessed a small dip, contributing 5% to the revenue.
Capital Allocation and Shareholder Returns
As part of its capital allocation strategy, Ascom proposed a dividend of CHF 0.10 per share and announced a share buyback program aimed at purchasing up to 10% of its outstanding share capital, amounting to a potential CHF 15 million over the next 18 months. This program is believed to support capital reduction while providing returns to shareholders in a challenging economic climate.
Exploring Order Backlogs
Despite the revenue dips, Ascom’s order intake reached CHF 307.4 million, reflecting a slight decrease from CHF 318.6 million in 2023. However, certain regions showed promise, with the Rest of World and OEM business sectors exhibiting double-digit growth. The company's order backlog concluded at CHF 301.5 million, signifying a positive outlook as they advance into the new year.
Profitability Insights
Ascom reported an EBITDA of CHF 21.3 million for 2024, which translates to an EBITDA margin of 7.4%. This decline in profitability compared to the previous year's CHF 30.1 million is attributed to rising investments in research and development coupled with elevated costs. Notably, the gross profit also saw a drop, landing at CHF 133.3 million, which indicates a decrease in the gross margin percentage from 47.6% the previous year to 46.5% in 2024.
Company’s Financial Health
The financial stability of Ascom remains strong, demonstrated by a positive cash flow from operating activities amounting to CHF 20 million. The net cash position as of December 31, 2024, stood at CHF 18.6 million, and the company reported no outstanding borrowings. Shareholders’ equity presented a solid figure of CHF 74.4 million, indicating resilience amidst challenging market conditions.
Growth Forecast for 2025
Looking forward to 2025, Ascom is optimistic about achieving low single-digit revenue growth at constant currencies, along with aspirations to maintain an EBITDA margin of around 9-10%. The company anticipates leveraging previous investments to enhance its performance and improve customer experiences.
Leadership and Strategic Changes
As part of their ongoing commitment to growth, Ascom reaffirms the continuity in leadership. All members of the Board of Directors are standing for re-election, with Dr. Valentin Chapero seeking a final term before transitioning from the role in 2026. The company will also see Dr. Daniel Lack stepping down, with Ms. Kalina Scott slated to inherit investor relations endeavors moving forward.
Frequently Asked Questions
What were Ascom's net revenues for 2024?
Ascom reported net revenues of CHF 286.7 million for 2024.
How much is the proposed dividend for shareholders?
Ascom proposed a dividend of CHF 0.10 per share for the upcoming annual general meeting.
What investment strategies are included in Ascom’s plans?
The company has announced a share buyback program and increased investments in R&D and marketing.
What is the predicted growth for Ascom in 2025?
Ascom expects to achieve low single-digit revenue growth and an EBITDA margin of around 9-10% for 2025.
Who are the key figures in the leadership change at Ascom?
Dr. Valentin Chapero and Dr. Daniel Lack are notable figures involved in the leadership transition.
